Dianthus Therapeutics, Inc. (DNTH)
85.51
-2.53
(-2.87%)
USD |
NASDAQ |
Oct 06, 16:00
85.51
0.00 (0.00%)
After-Hours: 17:01
Dianthus Therapeutics Price : 85.51 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 88.44 | 89.58 | 86.09 | 88.04 | 597421.0 |
| Oct 02, 2026 | 89.05 | 91.24 | 87.73 | 88.21 | 751386.0 |
| Oct 01, 2026 | 88.40 | 91.04 | 87.22 | 88.32 | 767034.0 |
| Sep 30, 2026 | 88.19 | 90.71 | 87.58 | 88.05 | 1.031M |
| Sep 29, 2026 | 87.40 | 87.69 | 84.72 | 87.16 | 1.034M |
| Sep 28, 2026 | 88.03 | 89.14 | 87.04 | 87.83 | 652710.0 |
| Sep 25, 2026 | 91.56 | 92.88 | 88.34 | 88.55 | 522725.0 |
| Sep 24, 2026 | 93.75 | 94.95 | 90.36 | 90.71 | 726361.0 |
| Sep 23, 2026 | 98.35 | 98.53 | 89.78 | 93.44 | 1.187M |
| Sep 22, 2026 | 96.84 | 100.47 | 96.55 | 98.35 | 1.127M |
| Sep 21, 2026 | 95.95 | 99.67 | 94.58 | 96.47 | 933209.0 |
| Sep 18, 2026 | 101.12 | 104.55 | 96.46 | 96.81 | 2.829M |
| Sep 17, 2026 | 104.58 | 105.84 | 99.92 | 101.12 | 1.141M |
| Sep 16, 2026 | 105.43 | 107.00 | 101.60 | 102.49 | 1.036M |
| Sep 15, 2026 | 107.85 | 108.26 | 104.04 | 104.77 | 478964.0 |
| Sep 14, 2026 | 108.36 | 109.76 | 106.55 | 107.69 | 651470.0 |
| Sep 11, 2026 | 106.78 | 109.78 | 105.00 | 106.20 | 732764.0 |
| Sep 10, 2026 | 105.88 | 107.64 | 101.60 | 103.28 | 535941.0 |
| Sep 09, 2026 | 108.03 | 110.24 | 105.94 | 107.04 | 1.034M |
| Sep 08, 2026 | 105.61 | 111.11 | 104.95 | 109.13 | 631129.0 |
| Sep 04, 2026 | 107.06 | 109.61 | 105.65 | 108.10 | 638559.0 |
| Sep 03, 2026 | 106.44 | 109.23 | 105.57 | 107.85 | 355693.0 |
| Sep 02, 2026 | 107.69 | 110.44 | 103.13 | 106.24 | 565394.0 |
| Sep 01, 2026 | 105.34 | 107.52 | 103.80 | 106.62 | 576600.0 |
| Aug 31, 2026 | 105.33 | 107.20 | 102.38 | 105.61 | 459376.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Verastem, Inc. | 7.76 |
| ACADIA Pharmaceuticals, Inc. | 19.74 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Savara, Inc. | 4.645 |
| Vericel Corp. | 40.05 |
Price Related Metrics
| PS Ratio | 2097.64 |
| PEG Ratio | -0.7470 |
| Price to Book Value | 3.998 |
| Earnings Yield | -4.86% |
| Market Cap | 4.686B |
| PEGY Ratio | -0.7470 |